These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12088081)

  • 21. Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine or valproic acid.
    Prodam F; Bellone S; Casara G; De Rienzo F; Grassino EC; Bonsignori I; Demarchi I; Rapa A; Radetti G; Bona G
    Epilepsia; 2010 Feb; 51(2):312-5. PubMed ID: 19780793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid.
    Nisha Y; Bobby Z; Wadwekar V
    Seizure; 2018 Aug; 60():57-60. PubMed ID: 29906708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of valproate on sexual development].
    Balaguer Martínez JV; López García MJ; Andrés Celma M; Contell Villagrasa A; Castelló Pomares ML
    An Pediatr (Barc); 2003 May; 58(5):443-8. PubMed ID: 12724077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocrine effects of valproic acid therapy in girls with epilepsy: a prospective study.
    Goldberg-Stern H; Yaacobi E; Phillip M; de Vries L
    Eur J Paediatr Neurol; 2014 Nov; 18(6):759-65. PubMed ID: 25139344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of excessive weight gain in epileptic children treated with valproate.
    Novak GP; Maytal J; Alshansky A; Eviatar L; Sy-Kho R; Siddique Q
    J Child Neurol; 1999 Aug; 14(8):490-5. PubMed ID: 10456757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome.
    Yucel A; Noyan V; Sagsoz N
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):81-6. PubMed ID: 16337726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiepileptic drugs alter reproductive endocrine hormones in men with epilepsy.
    Røste LS; Taubøll E; Mørkrid L; Bjørnenak T; Saetre ER; Mørland T; Gjerstad L
    Eur J Neurol; 2005 Feb; 12(2):118-24. PubMed ID: 15679699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of valproic acid-associated weight gain in prepubertal children.
    Espinosa PS; Salazar JC; Yu L; Mendiondo MS; Robertson WC; Baumann RJ
    Pediatr Neurol; 2008 Sep; 39(3):177-80. PubMed ID: 18725062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating levels of allopregnanolone, a neuroactive steroid, and leptin during treatment with valproic acid in children with epilepsy.
    Grosso S; Luisi S; Mostardini R; Matera M; Barlocco EG; Casarosa E; Balestri P; Petraglia F
    Neuroendocrinology; 2011; 93(3):159-64. PubMed ID: 20980729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The decrease in luteinizing hormone secretion in response to weight reduction is inversely related to the severity of insulin resistance in overweight women.
    Bützow TL; Lehtovirta M; Siegberg R; Hovatta O; Koistinen R; Seppäla M; Apter D
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3271-5. PubMed ID: 10999821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid.
    Greco R; Latini G; Chiarelli F; Iannetti P; Verrotti A
    Neurology; 2005 Dec; 65(11):1808-9. PubMed ID: 16344528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproate, weight gain and carbohydrate craving: a gender study.
    El-Khatib F; Rauchenzauner M; Lechleitner M; Hoppichler F; Naser A; Waldmann M; Trinka E; Unterberger I; Bauer G; Luef GJ
    Seizure; 2007 Apr; 16(3):226-32. PubMed ID: 17210261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased oxidative stress in epileptic children treated with valproic acid.
    Verrotti A; Scardapane A; Franzoni E; Manco R; Chiarelli F
    Epilepsy Res; 2008 Feb; 78(2-3):171-7. PubMed ID: 18164182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of valproate or lamotrigine monotherapy on the reproductive endocrine and insulin-related metabolic profile in Chinese adults with epilepsy: a prospective randomized study.
    Kwan P; Yip FP; Hui AC; Leung H; Ng PW; Hui KF; Chan IH; Chan MH; Lam CW
    Epilepsy Behav; 2009 Apr; 14(4):610-6. PubMed ID: 19435587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metabolic syndrome in overweight epileptic patients treated with valproic acid.
    Verrotti A; Manco R; Agostinelli S; Coppola G; Chiarelli F
    Epilepsia; 2010 Feb; 51(2):268-73. PubMed ID: 19682024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weight gain and insulin resistance in children treated with valproate: the influence of time.
    Masuccio F; Verrotti A; Chiavaroli V; de Giorgis T; Giannini C; Chiarelli F; Mohn A
    J Child Neurol; 2010 Aug; 25(8):941-7. PubMed ID: 20207607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
    Apter D; Bützow T; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease during valproate therapy.
    Verrotti A; Di Marco G; la Torre R; Pelliccia P; Chiarelli F
    Eur J Pediatr; 2009 Nov; 168(11):1391-4. PubMed ID: 19184102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.